Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, September 17, 2019
Parexel has formed alliances with three healthcare institutions - PKUCare Luzhong Hospital, West China Medical Center, and Shanghai Xuhui Central Hospital.
read more
OmniaBio Inc. announced the opening of a new North American cell and gene therapy (CGT) manufacturing and artificial intelligence (AI) centre of excellence, which is now Canada's largest contract development and manufacturing organization (CDMO) ...
read more
Wednesday, January 02, 2019
HOOKIPA Pharma announced that it has achieved its first research milestone in its collaboration and license agreement with Gilead Sciences.
read more
ReForm Biologics announced a collaboration with Astellas Pharma to reduce the viscosity of an Astellas clinical-stage biological pipeline program.
read more
The FDA is committed to helping facilitate American patients’ access to lower-cost generic medicines by taking steps to enhance and streamline the development and approval process of high-quality generic drugs.
read more
Friday, February 15, 2019
Jubilant Biosys announced a new integrated drug discovery collaboration with Sanofi in the CNS therapeutic area.
read more
Tuesday, September 21, 2021
Ichor Therapeutics is now known as Ichor Life Sciences. The new name reflects Ichor Life Sciences’ emphasis on delivering premium preclinical contract research and custom programs in discovery through pharmacology from its R&D facilities in LaFayette...
read more
Thursday, October 14, 2021
The Department of Air Force, in coordination with the Department of Health and Human Services (HHS), awarded a $30 million contract to Eurofins Genomics US to build a new production facility and expanded capacity for the manufacturing of reagents ...
read more
SmartLipo365 is voluntarily recalling 122 lots of Smart Lipo (800, 900, 950 mg) capsules, to the consumer level. FDA received samples of 800 and 900mg capsules of Smart Lipo and the lab results found the Smart Lipo products to contain undeclared ...
read more
Worldwide Clinical Trials has selected Medidata Payments Cloud to streamline accurate, timely payments on behalf of their clinical trial sponsors.
read more
Thursday, August 27, 2020
GI Partners has completed the previously announced acquisition of Clinical Ink, a global clinical trial technology company.
read more
Albumedix has announced that its albumin-based VELTIS® half-life extension technology is being used by CSL Behring in IDELVION®, a therapy recently authorized for the treatment of haemophilia B in the U.S.
read more
Wednesday, September 07, 2022
Charles River Laboratories International and Cure AP-4, a non-profit foundation dedicated to raising funds and awareness about Adapter-Protein 4 Hereditary Spastic Paraplegia (AP-4 HSP), have announced a manufacturing collaboration.
read more
DelMar Pharmaceuticals announced the closing of a $9 million offering of common stock and warrants which was led by leading healthcare dedicated institutional investors.
read more
Spheryx announced the NIH has awarded the company a Phase II SBIR grant to support the modification of their proprietary Total Holographic Characterization technology.
read more